Infection is a common natural stressor on the haematopoietic system. Immune cells are consumed in the fight against invading pathogens, either by mobilization to sites of infection or by apoptosis 1 . Homeostasis within the haematopoietic system depends on the replacement of these immune effector cells by haematopoietic precursors. For example, common myeloid progenitors (CMPs) in the bone marrow and peripheral blood can quickly produce large numbers of neutrophils in response to sepsis 2 . The contribution of the most primitive of the haematopoietic progenitors, the haematopoietic stem cell (HSC), to haematopoietic homeostasis during infection is a new area of investigation.
HSCs are rare, multipotent cells that are capable of generating all the cells of the blood and immune systems over the lifespan of an organism (FIG. 1) . Usually residing in a quiescent state in the bone marrow, HSCs represent a reservoir of pluripotent cells that replenish other haematopoietic populations as they are depleted by age or use. The factors that determine how the HSC population is maintained over the lifespan of an organism, or those that trigger differentiation into mature haematopoietic cell types, are the subject of ongoing investigation.
Recent studies have changed our fundamental understanding of HSC biology. These studies indicate that HSCs are first responders to infection, and that pro-inflammatory cytokines released during infection -such as tumour necrosis factor (TNF), interleukin-1 (IL-1), IL-6, IL-8 and type I and type II interferons (IFNs) -are crucially important to HSC regulation. Indeed, pro-inflammatory cytokines appear to be required to maintain the appropriate number of HSCs, and for the proliferation and differentiation of HSCs, both under homeostatic conditions and in response to stress. Furthermore, dysregulation of such pro-inflammatory cytokines, and the consequent impact of this on the earliest haematopoietic progenitors, may be a major contributor to the haematological abnormalities that occur in ageing individuals and in patients with bone marrow failure syndromes or cancer. In this Review, we discuss the different ways in which the pro-inflammatory cytokines released during infection and inflammation can shape the HSC compartment.
HSCs as a foundation for the immune response
Even though HSCs are long-lived and frequently dormant 3 , recent studies suggest that HSCs participate directly in the primary response to both acute and chronic infections (FIG. 2) . In one study, mice were infected with Escherichia coli by intrapulmonary injection and the bone marrow was collected at subsequent time points for phenotypic analysis of haematopoietic cell types. Infection led to the expansion of lineage marker-negative SCA1 + KIT + cells (LSK cells), a population of haematopoietic stem and progenitor cells in the bone marrow, even in the absence of a period of leukopenia 4 
. Notably, levels of the stimulatory cytokine granulocyte colony-stimulating factor (G-CSF) have been shown to be elevated in the serum of mice during systemic bacterial infection 5 . These
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(CMPs). Progenitor cells that give rise to megakaryocyte and erythrocyte progenitors (MEPs) or granulocyte and macrophage progenitors (GMPs) and, subsequently, the mature progeny of those cells. Long-term haematopoietic stem cells (HSCs) have the capacity to self-renew over the lifespan of an animal and also to give rise to all the cell types of the bone marrow and peripheral blood. Other pluripotent progenitors, short-term HSCs and multipotent progenitors (MPPs) have less self-renewal capacity. Together, these three cell types constitute the haematopoietic stem and progenitor cell (HSPC) population. MPPs are thought to differentiate into the two main branches of haematopoietic development that arise from the common lymphoid progenitor (CLP) and the common myeloid progenitor (CMP). This process is more complex and nuanced than shown here. Mature peripheral blood cells, shown on the right, are derived from these progenitors. GMP, granulocyte and macrophage progenitor; MEP, megakaryocyte and erythrocyte progenitor; NK, natural killer. findings suggest that bone marrow progenitors respond directly to the infection itself, rather than to secondary peripheral cytopenia (FIG. 2) . Similar stimulatory effects on the LSK cell compartment have been observed in polymicrobial, viral and candidal models of systemic infection [6] [7] [8] . Recently, inflammatory conditions have been shown to increase proliferation and self-renewal among LSK cells. The rate and extent of cell division can be determined precisely by measuring the dilution of the fluorescent dye 5,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) over time. When mice containing CFSElabelled bone marrow cells were exposed to lipopolysaccharide (LPS) over an 8-day period, LSK cells were noted to expand in number and to display accelerated dye dilution, indicating a higher rate of cellular proliferation compared with control cells. These findings suggest that inflammation triggered by LPS exposure can induce the proliferation of haematopoietic progenitor cells 9, 10 . Studies focusing on the LSK compartment of the bone marrow are limited by the inherent heterogeneity of that cell population, as well as by the effects of inflammation on common phenotypic markers of stem cells
.
As the LSK cell compartment is a diverse mixture of HSCs and lineage-committed progenitor cells, it is erroneous to infer that effects on the LSK cell compartment apply to the HSC subpopulation. In order to delineate the effects of inflammation on HSCs, we conducted an analysis of the bone marrow following Mycobacterium avium infection using more discriminating purification schemes. It is possible to exclude committed progenitor populations and enrich more specifically for HSCs by using additional immunophenotypic criteria -such as CD34 -, CD48 -, CD150
+ and FLT3 -(FMS-related tyrosine kinase 3; also known as FLK2) -or by assessing the functional capacity for efflux of the dye Hoechst 33342 to identify the so-called 'side population'
. Using these techniques, we found that HSCs proliferated in response to chronic M. avium infection 11 . Notably, M. avium causes a chronic indolent infection, and peripheral blood counts, as well as the numbers of committed progenitors, are never very low during the 4-week course of this infection. Thus, the finding of increased proliferation of HSCs during this infection implies that HSCs divide as part of the primary immune response rather than simply to replace depleted progeny pools. In other words, in addition to the 'pull' effect that peripheral cell deficiencies may have on HSCs, HSCs can also be 'pushed' towards cell division and differentiation by infection (FIG. 2) .
HSCs may sense infection directly
Having established that HSCs respond to infectious states even in the absence of peripheral cytopenia, we turn to the question of how the infectious state is sensed by the HSC. One may imagine three different scenarios. First, the HSC itself may be infected, leading to direct effects on intracellular organelles. Alternatively, pathogenic organisms may signal directly to the HSC, for example by releasing pathogen-associated molecular patterns (PAMPs) that bind to receptors in or on the HSC. A final possibility is that alterations in the HSC environment as a result of infection, including changes in the cellular composition or the cytokine environment, may lead to indirect changes in the HSC. These indirect changes could be mediated by a broad range of factors, such as cell-cell interactions, microRNAs and epigenetic factors. Certainly, the above-mentioned scenarios are not mutually exclusive (FIG. 3) .
The possibility that HSCs are affected by direct invasion of pathogenic bacteria has not been borne out experimentally. In animal models, HSCs are not commonly infected by pathogens themselves. Even when animals are systemically infected, or when purified HSCs are incubated with high concentrations of bacteria in vitro, HSCs have been found to be resistant to infection by a variety of intracellular pathogens, including respiratory viruses, Salmonella spp., Listeria spp. and Yersinia spp. 12, 13 . In our studies using M. avium infection, we have not observed viable bacteria within the HSCs 11 . Hence, changes in the proliferative rate of HSCs or in their capacity to engraft and repopulate the bone marrow following transplantation are probably not attributable to the presence of intracellular pathogens. On the other hand, haematopoietic progenitors do possess the machinery to directly sense infectious particles. Toll-like receptors (TLRs) -the major cell surface receptors for detecting PAMPs -are present on the surface of haematopoietic progenitors 10 . Ligation of TLR4 on early haematopoietic progenitors leads to the proliferation and differentiation of these cells, with increased generation of CMPs and the preferential differentiation of lymphoid progenitors into dendritic cells 10 . TLR4 is the main receptor for LPS, and it is required for expansion of the LSK cell compartment in the bone marrow of mice infected with Pseudomonas aeruginosa 14 . Furthermore, in mice treated with low-dose LPS, longterm stimulation of TLR4 leads to impaired long-term self-renewal of HSCs and lower numbers of common lymphoid progenitors (CLPs) 15 . Studies that address the cell-autonomous functions of TLRs on haematopoietic stem and progenitor cells (HSPCs) and the degree to which HSCs react in a TLR-specific way to different infectious agents will be of great interest in the future.
HSC responses to infection may also be mediated by changes in the immediate microenvironment. A range of studies has indicated that HSC fate is strongly influenced by other cells in the specialized HSC microenvironment, termed the HSC niche. For instance, retention of the HSC in an area close to an osteoblast, which produces important regulatory cytokines, may be required for the maintenance of HSC quiescence 16 . Infection probably leads to changes in the HSC niche that contribute to changes in HSC biology. For example, exposure to TLR ligands suppresses the maturation of osteoclasts in the bone marrow niche, a condition that may lead to the mobilization and differentiation of HSPCs 17, 18 . Similarly, G-CSF represses CXC-chemokine ligand 12 (CXCL12) production by osteoblasts and leads to increased mobilization of HSPCs 19 . Complement activation can lead to HSC mobilization indirectly by promoting granulocyte egress 20, 21 . Recently, bone marrow-resident macrophages have been shown to govern HSC retention within the bone marrow niche 22 . It is interesting to speculate that these macrophages may be recruited to sites of infection and that egress of these cells from the HSC niche may, secondarily, result in HSC proliferation and mobilization. These questions remain experimentally untested.
Indirect HSPC responses to infection
Aside from direct sensing of pathogens, quantitative changes in the HSPC compartment and in HSC activity in response to infection appear to be mediated by pro-inflammatory cytokines. Expansion of LSK cell populations in response to E. coli infection is mediated by LPS via TNF and nuclear factor-κB (NF-κB) signalling 5 . In a recent study, HSCs (defined as FLT3   -CD150   +   CD48   -CD34 -LSK cells) proliferated but showed defective long-term engraftment potential following combined exposure to IL-6, TNF and CC-chemokine ligand 2 (CCL2), all of which are pro-inflammatory cytokines induced by LPS exposure 23 . Inhibition of these three cytokines rescued the quantitative and functional effects of LPS treatment on HSCs. The finding that the proliferation of HSCs is not affected by the ablation of a single TLR-or type I IFN-mediated signalling pathway during polymicrobial sepsis indicates that there are probably multiple redundant cytokine pathways for HSC activation during infection 24 . In a recent study using M. avium infection in mice, we reported that HSC activation could be triggered by IFNγ signalling. Furthermore, this activation could be recapitulated by short-term exposure of purified HSCs to IFNγ in vitro, showing that HSC activation can be triggered directly by an IFN-mediated immune response to infection, regardless of the chronicity of the infection or the presence of other cell types 11 . The finding that IFNγ can activate HSC proliferation was surprising in light of long-standing studies showing that patients with bone marrow failure syndromes frequently have high serum levels of IFNγ
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. Very high IFNγ levels are thought to trigger apoptosis of haematopoietic cells, leading to hypocellularity of the bone marrow. Indeed, exposure of human CD34 + HSCs to IFNγ can lead to expression of pro-apoptotic genes in in vitro studies 26 . Furthermore, IFNγ exposure leads to reduced colony formation in cultured human bone marrow cells 27, 28 . However, apoptosis may not be the only mechanism for bone marrow failure in the setting of elevated IFNγ levels. A number of studies suggest that the level of IFNγ, as well as the particular cell type under examination, may be pivotal for the nature of the response. For example, two groups found that in vitro IFNγ treatment increased the cell viability and colony formation of human CD34 + cells 29, 30 . Similarly, haematopoietic progenitors were stimulated to proliferate and showed increased colony-forming ability in a mouse model of Plasmodium chabaudi infection 31 or when mice were injected with recombinant IFNγ 32 . In our studies, in vitro treatment of mouse HSCs with IFNγ led to increased cellular proliferation, rather than apoptosis 11 . Treatment of mouse HSCs with IFNα or polyinosinicpolycytidylic acid (polyI:C), which triggers an IFNα response, has a similar activating effect 33 . Indeed, experiments using chimeric mice that had both HSCs isolated from wild-type mice and HSCs isolated from mice lacking the IFNα receptor indicated that HSCs could be selectively activated via IFNα signalling. These findings highlight the direct, cell-autonomous impact of IFN signalling on HSC function (FIG. 2) . Thus, the weight of evidence indicates that IFNs are activating rather than inhibitory for highly purified HSCs, although this may not be true for more differentiated haematopoietic progenitors. Further studies are required to understand the potential crosstalk between type I and type II IFNs in HSC activation, as well as the dual action of inhibitory and activating effects. The duration and context of HSC exposure to IFNs are likely to be pivotal in guiding HSC responses, and these factors are also important areas for future investigation.
Box 1 | A word about HSCs
Haematopoietic stem cells (HSCs) are defined experimentally in a variety of ways; hence, it is useful to briefly discuss these definitions. HSCs are rare cells that constitute less than 0.01% of bone marrow leukocytes and cannot be propagated by in vitro culture without differentiation. The gold standard for identification of an HSC is to conduct bone marrow transplantation and demonstrate generation of all blood lineages for at least 16 weeks in mice. An assay that can be used as an adjunct is to test the ability of bone marrow cells to form colonies in methylcellulose culture medium; however, this method does not differentiate between HSCs and committed progenitor cells.
Transplantation or methylcellulose culture is impractical for many forms of experimental manipulation, so surrogate methods have been developed. Most commonly, mouse HSCs are defined immunophenotypically using cell surface markers. A cocktail of antibodies specific for antigens, termed 'lineage markers', that are characteristically expressed by differentiated blood cells can be used to separate out mature haematopoietic cell types. The lineage marker-negative SCA1 + KIT + (LSK) fraction of bone marrow cells is enriched for haematopoietic stem and progenitor cells (HSPCs). Although the LSK population is commonly studied, it is heterogeneous and includes multipotent progenitors and other committed progenitors that do not maintain long-term reconstitution potential 
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-fraction of LSK cells 57 . Use of cell surface markers is convenient and allows for manipulation of cells by flow cytometry. However, one must be aware of changes in cell surface marker expression owing to environmental conditions that can change the population represented by those markers. For instance, stem cell antigen 1 (SCA1) expression is known to be upregulated by interferon-γ (IFNγ) 58 . Therefore, unless definitions are strictly employed, the expression of SCA1 can be misleading as a marker for the HSPC population. As an alternative or adjunct to immunophenotypic methods, HSCs can also be isolated based on functional properties such as their ability for Hoechst 33342 or rhodamine 123 dye efflux 59 . The so-called 'side population' of cells that are capable of Hoechst dye efflux or the cells that show low-intensity rhodamine staining are highly enriched for HSCs and can be further purified with additional selection of cell surface markers. These dye efflux methods are potentially less susceptible to the effects of environmental changes or to variations in antibody avidity for cell surface markers 60, 61 . The literature regarding HSPC responses to infection is highly contradictory, in part owing to the lack of uniformity in the methods and, hence, in which cell types are being examined. Clarity will be gained by studies that carefully define the HSPC subpopulation being addressed. The potency of IFNs in mediating HSC activation is underscored by the finding that stringent regulation of the IFN response is required for normal bone marrow function. When type I IFN responses are excessive (as in IFN-regulatory factor 2 (IRF2)-deficient mice), HSCs hyperproliferate and slowly decline in number over time, suggesting that overexposure to IFN signalling impairs HSC self-renewal processes 33, 34 . Similarly, mice that lack the RNA editing enzyme ADAR1 (which converts adenosine to inosine) display global upregulation of type I and type II IFN-inducible transcripts and loss of HSC populations 35 . This phenomenon also occurs in mice lacking immunity-related GTPase M1 (IRGM1); these mice display unrestricted IFNγ signalling and impaired HSC function 36 . Collectively, these studies indicate that chronic hyperstimulation by IFNs leads to HSC exhaustion. On the other hand, low steady-state levels of IFNs may have a different effect and may be required for maintaining peripheral cell populations (FIG. 4) . Longerterm studies to investigate the potential mechanisms of this phenomenon are needed.
Immunomodulation of HSPCs
Effects on HSC differentiation. Following the early progenitor stage, the haematopoietic 'tree' is traditionally thought to divide along two main branches: myeloid and lymphoid. Despite improved knowledge about lineage differentiation and the in vitro conditions that can lead to the production of specific cell types 37 , the factors that influence lineage fate decisions in vivo remain poorly understood. Because responses to infectious diseases tend to depend asymmetrically on either myeloid or lymphoid cells, it is tempting to speculate that infections can influence the differentiation pattern of cells even as primitive as the HSC.
Indeed, some studies suggest that immune-mediated effects on HSPCs may be important in influencing the balance of myeloid versus lymphoid haematopoietic differentiation. For instance, in a mouse model of malaria, IFNγ signalling led to the induction of an IL-7R + KIT hi myelolymphoid progenitor population that generated mainly myeloid cells to combat the infection 31 . Extramedullary HSPCs in tissues such as kidney have been found to be responsive to TLR ligands and to generate myeloid lineage cells in those tissues following TLR stimulation 38 . Hence, pathogen-associated or cytokine-mediated responses may help to tailor HSPC output to the infection at hand.
Lineage biasing of HSC output may be mediated by differential responses of HSC subtypes. Whereas HSCs have previously been treated as a homogeneous group, the field is now evolving towards a finer understanding of the HSC population. Namely, a variety of subsets exist within the HSC population, comprising either myeloidbiased or lymphoid-biased HSCs, which, while retaining the capability to fully reconstitute all blood lineages, show a tendency towards either myeloid or lymphoid cell development [39] [40] [41] . Cytokine-mediated selection of one HSC subset over another might be a clever way for the immune system to preferentially manufacture myeloid or lymphoid effector cells as appropriate for the situation. It will be of great interest in the coming years to understand how infectious states may specifically select for proliferation of one HSC class over another.
Effects on HSPC mobilization. Some researchers have suggested that cytokine signalling to HSCs may be a mechanism for recruiting HSPCs and immune effector cells from the bone marrow to distal tissue sites of infection. Infections appear to increase the number of HSCs that can be detected in the peripheral circulation 42, 38 . In one study, schistosomal infection appeared to alter the splenic microenvironment, making it more hospitable for HSPC homing 43 . However, it is unclear whether this phenomenon is important for immunity or whether it is simply a by-product of altered retention in the bone marrow niche. A recent study used a mouse model of pneumonia to investigate the effects of the cytokines that are released in the lung on bone marrow progenitors. Interestingly, exposure of bone marrow cells to cytokineladen serum from these mice appeared to influence leukocyte migration to the infected lungs and, ultimately, the outcome of the infection 12 . These findings suggest that serum factors condition bone marrow cells to home to sites of infection. To our knowledge, extramedullary haematopoiesis is not a common or important phenomenon in the absence of conditions that disrupt the bone marrow itself. Further studies are necessary to establish whether there is any role for HSCs at sites of infection.
Effects on HSC function. The idea that HSCs can be activated to divide and differentiate in response to infectious or inflammatory stimuli has important functional consequences for this stem cell population. Quiescence is an important characteristic of HSCs, and the total HSC population is best preserved when quiescent or even dormant 3 . In one study of Pseudomonas aeruginosamediated sepsis in mice, LSK cells from infected mice did not engraft well after transplantation into lethally irradiated mice, indicating a deficit in stem cell function 14 . Similarly, HSCs from mice infected with M. avium are highly defective in post-transplantation engraftment 11 . The functional defect of HSPCs from infected mice is consistent with the general finding that frequently dividing stem cells are functionally impaired in their ability to engraft in the setting of bone marrow transplantation 44 , and this suggests that they have an impaired self-renewal capacity.
Indeed, disruption of HSC quiescence through immune activation can have long-term consequences for the haematopoietic system. In fact, several recent studies have shown self-renewal defects of the HSC population in the setting of chronic inflammation. When genes that normally suppress IFN signalling are disrupted, mice have increased levels of IFN signalling and their HSC populations are depleted over time 34, 36 . Similarly, HSC populations were diminished in mice chronically exposed to LPS 15 . Conversely, when chimeric mice containing both wild-type HSCs and IFNα receptor-deficient HSCs were chronically exposed to IFNα, only the IFNα receptor-deficient HSCs survived 33 . Collectively, these findings indicate that immune-mediated bone marrow exhaustion can result from persistent activation of quiescent HSCs, thus depleting the total population of HSCs over time. This finding strikes at some of the core questions in stem cell biology: are we born with a finite number of stem cells, and are these cells limited to a finite number of cell divisions? Further studies investigating the effects of infection on the stem cell population over time promise to shed further light on these fundamental questions in the field.
Inflammatory mediators and HSC homeostasis
The finding that inflammatory signals activate HSCs raises a previously unconsidered question: do inflammatory signals contribute to HSC biology at baseline, even in the absence of infection? From the expansion of our knowledge of the human microbiome, we now understand that humans are rarely if ever in a state that is devoid of inflammatory stimulation 45 . Instead, we live among latent bacteria and viruses that provide a constant stimulus for some degree of inflammatory signalling. Recent studies of immune-mediated effects on HSCs have led to evidence that baseline inflammatory signalling is important for HSC function, even under homeostatic conditions. For example, mice that lack the TNF receptor p55 (also known as TNFR1) have increased bone marrow cellularity with age accompanied by a relative decrease in HSC function (as shown by transplantation assays) 46, 47 . Similarly, bone marrow from mice lacking IFNγ or TLR4 shows increased engraftment after transplantation when compared to bone marrow from a wild-type donor, probably because these cells are in a more quiescent state at baseline 11 . These findings suggest that the number or proliferative status of HSCs can be influenced by inflammatory or microbial signalling, even in the absence of active infection. Thus, a low-level inflammatory response may be required for the maintenance of normal stem cell and progeny populations. Indeed, immune activators such as IFNγ may serve as a biological rheostat for the haematopoietic system, providing a sensitive and rapid method for the modulation of haematopoietic cell output.
Acquired aplastic anaemia
A syndrome of bone marrow hypocellularity combined with peripheral pancytopenia.
Therapeutic relevance
There are enormous clinical implications to the understanding of immunomodulatory effects on HSC number and function. A wide variety of infectious diseases lead to bone marrow failure syndromes, and the pathophysiology of such syndromes has been poorly understood. Specifically, one-third of cases of acquired aplastic anaemia occur following an infectious process, such as EpsteinBarr virus or cytomegalovirus infection 48 . HIV infection is frequently accompanied by bone marrow suppression, even in patients who are not being treated with bone marrow-suppressing drugs, such as zidovudine (also known as azidothymidine) 49 . Finally, bone marrow suppression in tuberculosis has frequently been ascribed to underlying haematological disorders or granulomatous infiltration of the bone marrow, but the mechanism of this effect has not been thoroughly studied 50 . Pro-inflammatory cytokines released during these infections probably contribute to bone marrow failure in each case, and further understanding of this effect is paramount. For instance, IFNs may lead to apoptosis of haematopoietic progenitors in some circumstances, but might promote proliferation of those same cells in other conditions. The concentration and timing of IFN exposure is likely to be pivotal in the final outcome, and further studies are needed to clarify these effects. Improved understanding of the effects of immune activators on HSCs will lead to new approaches to address acquired aplastic anaemia syndromes and pancytopenia in the setting of infectious diseases.
Further knowledge about inflammatory signalling and HSCs may also provide benefits for HSC transplant recipients. During the initial engraftment period, recipients of HSC transplants are extremely immunosuppressed and thus show increased susceptibility to a wide range of infectious agents 51 . How the lack of cytokine signalling, combined with potentially severe infections, in the immediate post-transplant period affect HSC engraftment is now beginning to be better defined. Again, immunomodulatory approaches in such situations may improve the outcome of HSC transplantation by preserving HSC function, despite the deleterious consequences of inadequate or overabundant cytokine signalling.
Finally, studies of the association between inflammatory signalling and HSCs may yield advances in the treatment of haematological malignancies. Oncologists are increasingly focused on the role of cancer stem cells in driving persistent or residual disease, even following aggressive chemotherapy. If pro-inflammatory cytokines, such as TNF or IFNs, can drive differentiation and reduce the longevity of HSCs, these cytokines could be applied therapeutically to increase the sensitivity of cancer stem cells to chemotherapy 33 . Indeed, combining standard chemotherapy with IFNα treatment was recently shown to improve treatment outcome in patients with chronic myelogenous leukaemia 52, 53 .
Future directions and open questions
In summary, recent work has indicated that HSPCs are activated to proliferate in response to infections and the pro-inflammatory cytokines that are produced to combat these infections. Furthermore, new studies suggest that pro-inflammatory cytokines are important for the maintenance of the appropriate number and function of HSCs at baseline. Different haematopoietic cell types respond quite differently to pro-inflammatory cytokines, probably in a concentration-dependent manner. To eliminate confusion about the effects of inflammatory signals on HSPCs, it is of crucial importance to carefully define the particular HSPC subset being described using a combination of cell surface markers and functional properties. Studies using these techniques have allowed us to view the HSC in a new light. Rather than considering it to be a dormant cell that is called upon to proliferate only in times of extreme haematopoietic stress, we now view the HSC as a cell whose activity is constantly modulated by the shifting inflammatory environment. Furthermore, preliminary studies indicate that inflammatory signals can influence the pace and direction of HSC differentiation, suggesting that these signals have a direct and vital role in the primary immune response to infection.
These ideas suggest a great number of experimental opportunities. First, the specificity of the HSC response to the distinct patterns of pro-inflammatory cytokines that are elicited by different pathogens remains to be explored. Pro-inflammatory cytokines other than IFNs are also likely to influence HSC activity. Moreover, HSCs may respond differently to type I versus type II IFNs, which are induced to different extents by various pathogens, thereby tailoring their response to the type of infection at hand. Similarly, signalling through various TLRs may lead to pathogen-specific responses by HSCs.
Second, the effects of inflammation on the HSC niche remain undefined, but are likely to prove extremely influential in the HSC response to infection. Recent work has shown that stromal cells of the bone marrow niche play a pivotal role in regulating HSC quiescence 54 . Thus, it will be of great interest to determine how the cellular composition of the HSC niche changes during infection and for how long these changes persist. Further investigation in this area will also elucidate the effects of local versus systemic inflammatory signalling on the HSC compartment.
Finally, it will be of great interest to understand how chronic inflammatory conditions affect the human HSC population in the long term. We speculate that long-term activation of these cells during chronic inflammation may lead to the depletion of the HSC population or to longterm functional deficits, such as those that are seen in some acquired bone marrow failure syndromes. Human studies to augment the findings in animal models will be of importance in all of these avenues of investigation.
